Amolimogene bepiplasmid
N/A
Report date: 2026/05/12 09:09:28
Base Information
Drug NameAmolimogene bepiplasmid
Drug Alias Name +[9]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMgi Pharma Biologics, Inc
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesEisai Co LtdMgi Pharma Biologics, Inc
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A